chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 24Mar2021 at 16:00 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history included diabetes and allergy to walnuts and melon. Concomitant medications included insulin (MANUFACTURER UNKNOWN), levothyroxine (MANUFACTURER UNKNOWN), famotidine (MANUFACTURER UNKNOWN) and metformin (MANUFACTURER UNKNOWN); all on unknown dates for unspecified indications. The patient previously took miconazole nitrate (MONISTAT) and fluconazole (DIFLUCAN); both on unknown dates for unspecified indications and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Mar2021 at 16:00, the patient experienced throat felt irritated, blood pressure increased and face and neck became flushed. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of throat felt irritated, blood pressure increased and face and neck became flushed and included treatment with BENADRYL. The clinical outcome of the events throat felt irritated, blood pressure increased and face and neck became flushed was recovered on an unknown date in 2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.
830 mom called clinic to check to see if pt could recvd shots; pt stepped on nail 18AUG91, bit by dog 17AUG91; Mom fed pt two small candy bars a/inject pt appeared hyper & fussy; Mom called clinic to say pt was having problems; To MD t98.5;
Pt recvd 2nd dose of Hep B vax on 16OCT91 & immediately p/vax pt devel red hot rash @ inject site which spread to face, neck, & torso; also low grade fever; Pt taken to ER tx DPH; pt elected not to recvd 3rd dose;
Left arm was slightly sore for several days and on 10/01/09 was getting worse and on 10/12/09 having problems raising my left arm and having continuous pain.
The shortness of breath started a few hours after the vaccination and continued. It never went away. After 1 or 2 weeks I noticed that I also had a cough that would be present with the shortness of breath. It has gotten really noticeable now. Both the shortness of breath and the cough happens every day. Sometimes it is very mild and other times it is constant and very uncomfortable.  I keep on thinking it will go away but it hasn?t.
The patient started VIVOTIF oral vaccination (batch no: unknown) on 11.May.2009 for her trip on 25.May.2009 and administered all capsules at the scheduled times. On 22.May.2009 she developed swollen and painful lymph nodes under her arm. The symptoms were persistent at time of reporting. At the time of reporting they are still swollen, bilateral, however pain was relieving. Follow-up request was sent to the reporter on 23.Jun.2009 regarding batch no. and filling the VAERS form.
Admitted to medical and then transferred to Hospital. Tested positive 12/4/22 with unknown symptom onset. Treatment includes transitional care for weakness.
A report has been received from a Health Professional concerning a 7 year old, male subject, who had been receiving FLUMIST (Intranasal). FLUMIST (Intranasal) started on an unknown date. The reporter reported that they inadvertently gave expired FLUMIST which started on 16-Sep-2013. The outcome of the event of inadvertent gave expired FLUMIST is unknown. The report was considered to be non-serious.
Fierce cold; shivers; fever; headache; migraine; vomiting; Insomnia; This is a spontaneous report from a contactable consumer, the patient. A 20-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 19Apr2021 at 13:30 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. Medical history included migraines. The patient had slight berry allergy which was not dangerous. The patient did not receive any other medications within 2 weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 29Mar2021 at 13:30 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Apr2021 at 23:00, the patient experienced fierce cold, shivers, fever, headache, migraine, vomiting and insomnia. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the adverse events. The clinical outcome of the events fierce cold, shivers, fever, headache, migraine, vomiting and insomnia were resolving at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Slight fever feel, then chills. Tired. Main effect was pimple like rash that appeared on forearms and elbow area, fingers.  Then spread to neck and ears, some at other parts of body distributed randomly. Raised red bumps 3mm diameter, itchy and will pop if squeezed releasing small amount of clear fluid.
Developed fever and chills 8-12 hrs post injection associated with arthralgia myalgias, redness inferior to injection site. Temp greater than or equal to 102, with persistant fever 5 days post injection.
on 1/27 intense headache and fatigue began Overnight chills and high fever developed.  On 1/28 upon waking high fever developed with intense headache, loss of apatite, and fatigue. Symptoms persisted (high fever) until 1/31 at which point fever dropped and has not returned. However,  I developed a light pink rash on my torso, head, and neck and a little on my arms. Rash was not itchy or painful. Night of 2/1 developed hives on back, arms, torso, and groin area.
Pt got light-headed and then passed out about 5 minutes after administration of vaccine. Pt laid on floor and was given water until he felt better. Pt seemed to recover after about 15 minutes and walked out of store OK.
7PM localized pain at injection site right deltoid 10/04/06 am redness right deltoid to just elbow (anterior asp) warm to touch, slight swelling.
Started developing muscle ache along left chest and shoulder within a week of the vaccine. Tingling, itching, and a rash followed within a couple of days, after which I went to an urgent care where I was diagnosed with shingles.
had blood spew out of the injection site; This is a spontaneous report from a contactable consumer or other non-healthcare professional. This consumer reported for 3 patients, this is 2 of the 3 reports. A patient of unspecified age and gender received bnt162b2 (BNT162B2, Pfizer Covid-19 Vaccine, Solution for injection), dose 2, via an unspecified route of administration on 23Jan2021 (Batch/Lot number: E19126 and Expiry date was not reported) as DOSE 2, SINGLE for covid-19 immunization. The patient medical history and concomitant medications were not reported. On 23Jan2021, the patient experienced had blood spew out of the injection site. It was explained that the bleeding lasted about an hour, it was not a lot but shot right out of the puncture, where the jab was at the injection site. The reporter wanted to know if he should get a third dose of the vaccine. It was reported that when he received the 2nd dose the patient lost a lot of blood, there was excess bleeding at the injection site. The caller stated that the tech put the needle in and afterward states that he was the 3rd patient that had blood spew out of the injection site. No other information provided for this statement as the caller declined to complete the report. The clinical outcome of the event was unknown.  Information on Lot/Batch number was available. Additional information has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021760093 same reporter/product/event, different patient
Admit for COVID pna. Fully vaccinated 3/2021. Out of range for remdesivir and plasma. Steroids, O2, vit-c, vit-d, zinc, singulair, ivermectin, zithromax, doxy. Weaned to 3 L and discharged home with O2.
Patient states she had pain immediately at site of injection. Pain, soreness, arm difficult to lift - started soon after injection and is still present on 11/2/2020 (approx 2 weeks later). States no redness, swelling or raised areas
Received vaccine Saturday afternoon.  Sunday morning while lying in bed, developed: -high heart rate -heavy, labored breathing -pulse oximetry showed oxygen saturation dropped down to 90 Symptoms are consistent with myocarditis or pericarditis
ESRD, patient stated shunt for dialysis did not work do to arm swollen. Non productive cough and shortness of breath. Fully vaccinated case with positive Covid-19 test.
Had my flu shot but still got the flu; Initial information received on 09-Nov-2022 regarding an unsolicited valid social-media non-serious case received from a consumer.  This case involves an patient with unknown age gender who experienced had my flu shot but still got the flu while receiving vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a unknown dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (formulation, strength, dose, route, administration site and lot number not reported) for Flu.  On an unknown date the patient had developed a non-serious event had my flu shot but still got the flu (influenza) (unknown latency) following the administration of INFLUENZA VACCINE.  Action taken: not applicable.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome was Unknown for the event.
Rash that started on the arm at injection site and then moved up to neck and head. Patient says the itching it still there after almost a week.
Chronic full body muscle weakness, chills, hip joint soreness, fatigue, Fell in bedroom Tuesday 05/29/18, pre-dawn, unable to get up for appx an hour. Fell in bathroom Thursday 05/31/2018, 6:30am, unable to get up until 7:30am. No strength to get up.
Atrial Fibrillation with rapid ventricular response, new onset-rate now controlled on Diltiazem however Afib persists. Only symptoms "felt loopy" Wife is a physician and heard Afib upon auscultation Hospitalized for 2 days at: Hospital
Woke up at about 3:30am feeling warm. Checked my temperature and it was 101.4. Also experienced joint aches and a headache.
This spontaneous report was received from a nurse (patient's mother) refers to a male patient of unknown age. Information regarding patient's medical history, concurrent condition and concomitant therapy was not provided. Patient's mother stated that the patient received 3 doses of GARDASIL, but on the following dates: first dose on 11-JUL-2013, second dose on 05-JUN-2014 and third dose on 30-DEC-2015 (inappropriate schedule of drug administration). No adverse effect was reported. This is one of the two reports received from the same reporter. Additional information has been requested.
Complains off awakening with itchy rash to torso and upper legs approximately 12 hours after vaccination. At 0820 10/8/10 presents with flat red rash to torso and upper thighs. No wheezing or respiratory complaints. Afebrile. BENADRYL 25mg (dose per patient request) given and referred to MD for evaluation.
[Casirivimab/imdevimab] treatment under Emergency Use Authorization(EUA): 82 yo with several medical problems including obesity, DM, sleep apnea and CAD. He had mild symptoms starting Friday or Saturday 1/9/2021 (with low grade fever and also a cough), did not feel it was COVID-19, received COVID-19 vaccine (mRNA based, Maderna) on Monday this week (1/11/2021). Patient's wife noted symptoms herself on Tuesday 1/12, got tested, positive for COVID-19, thus patient (husband) also got tested, he also tested positive for COVID-19 via NP swab testing on Wednesday (1/13/2021). Patient had fevers to 103-104 over the last two days, some cough and sputum production. Patient received casirivimab/imdevimab 1/14. His baseline O2 sat 95% on RA. BP 134/74. Tolerated infusion without issue. Approximately 30 minutes after end of infusion, he c/o rigors, SOB and dry heaves. Rigors treated with hydrocortisone 50 mg x2. BP stable, T 39.4 with sudden respiratory decline and accessory muscle use, O2 sat falling to 80%, placed O2 4l NC. RR 30 P 133, dusky color. Became air hungry and gasping, put on 100% NRB and transferred to ER for admission. In ER received epinephrine, diphenhydramine, famotidine, and dexamethasone for possible anaphylaxis. Unclear if anaphylaxis vs worsening COVID. Patient transferred to medical ICU.
At the time of administration no signs or symptoms were shown. Vaccination was given at 2:10 pm on 7/7/2023.
Developed extremely pain in arm 3 hours after injection until the next day. Developed chills and weakness in the middle of the night. Extreme fatigue. Slept through most of the next day until 4pm and then went to sleep at 9 and slept through til next morning. Noticed red blotchy rash across my stomach and chest area. It was a little itchy too. The nurse also found the rash inside my elbow joints, my back, and the back of my neck.
Pt complained of red and swollen left deltoid. Site of Pneumovax injection on 4/26/06.
I had arm soreness the day of the vaccine (2/11/21). The following day I noticed an erythematous round lesion that was very tender and when palpated felt like a lump. The pain went away 2-3 days after the vaccine and the erythema/lump went away on 2/21/21. On 2/19/21 my left internal arm felt sore. I thought I pulled a muscle perhaps. On 2/21/21 the arm pain was worse and didn't feel like typical soreness that would come from exercise or sleeping in the wrong position. It was painful when I pulled my arm close to my body, as if something were being compressed. I palpated in the armpit and found a large lump slightly smaller than a golf ball. It was extremely tender and sent me into a panic. Someone pointed out it was the same arm as my vaccination, so I looked it up and learned about this side effect. Today (2/22/21), the pain is gone and the lump is smaller (feel like a typical enlarged lymph node).
Patient was given a >12y vaccine instead of the 5-11 formulation. He did not have any adverse effects, I informed his father and patient immediately after the event and they were told to communicate to me immediately for any unusual or significant symptoms.
Skin Normal except as noted 13.5cm by 11.5cm area of erythema surrounding central punctate injection site on left vastus lateralis. Warm to touch with swelling at site of erythema. No streaking on extremity. No involvement of hip or knee joints. Covering for cellulitis with KEFLEX today. Advised using cool compresses and ok to continue ibuprofen and BENADRYL. Area of erythema and warmth marked with a pen.
Lack of coordination on right side - walking, righting, typing; Slurred speech; Dizziness; Symptoms first noticed one week following vaccination. Decided to go to emergency room when symptoms did not subsided after four days. Admitted to hospital on 3/22/21. Diagnosed as having Pontine CVA on left side of brain stem and small aneurysm detected in addition to and determined not to be the cause of stroke.
pt recvd vax;p/ dose 1, exp inject site soreness;same eve as dose 2, exp a low grade t, stomach cramps & hot flashes;
flu like symptoms; dizzy; occasional fatigue; This case was reported by a consumer via other manufacturer and described the occurrence of influenza-like symptoms in a 67-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included palbociclib (Ibrance) for metastatic breast cancer and anastrozole (Arimidex) for metastatic breast cancer.   Previously administered products included Shingrix (1st dose received on an unknown date, kindly refer case US2019AMR124296).   On an unknown date, the patient received the 2nd dose of Shingrix. In April 2017, the patient started Ibrance 125 mg once daily (125 mg daily). In April 2019, the patient started Arimidex 1 mg once daily (1 mg daily). On an unknown date, unknown after receiving Shingrix, the patient experienced influenza-like symptoms (serious criteria hospitalization), dizziness and fatigue. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the influenza-like symptoms, dizziness and fatigue were recovered/resolved.   It was unknown if the reporter considered the influenza-like symptoms, dizziness and fatigue to be related to Shingrix.  Additional details were provided as follows: The patient received 2nd dose of shingrix on 6th May. The patient developed flu like symptoms for which he was on rest. There was no side effect from the Ibrance except for occasional fatigue, especially around 14th day of pill cycle. It was unknown if the reporter considered the influenza-like symptoms, dizziness and fatigue to be related palbociclib (Ibrance) and anastrozole (Arimidex).
25 minutes after shot. bright red hotflushed face; Tingly tongue; Itchy throat; Numb/tingly nose; 2 episodes of heart palpitations; This is a spontaneous report received from a contactable consumer, the patient. A 53-year-old non pregnant old female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER2613) via an unspecified route of administration in the left arm on 21Mar2021 at 16:00 (at the age of 53-year-old) as a single dose for COVID-19 immunisation. The patient medical history included menopause and thyroid issues. The patient was allergic to penicillin and amoxicillin. The patient received unspecified other medications in two weeks. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 21Mar2021 at 16:30 reportedly 25 minutes after shot the patient experienced bright red hot flushed face, tingly tongue, itchy throat, numb/tingly nose and two episodes of heart palpitations. The symptoms subsided within an hour or so. The patient was allergic to penicillin/amoxicillin and not sure if that was related. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the events. The clinical outcome of bright flushed face, palpitations, Itchy throat, Numb/tingly nose, tingly tongue was recovered on 21Mar2021.   No follow-up attempts are needed. No further information is expected.
A dose of YELLOW FEVER was mixed with the incorrect (sterile)diluent. Per DHA consultant, Dr.,  the member was contacted and advised to receive another dose on the same day with the correct diluent.
HCP reported no further AE since administration; PROQUAD was inadvertently administered to a 78 year old female patient; This spontaneous report was received from a registered nurse via company representative, referring to a 78-year-old female patient. The patient's pertinent medical history, previous drug reactions or allergies, and concomitant medications were not reported.  On 11-DEC-2020, the patient was inadvertently vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) 0.5 milliliter one time for prophylaxis (strength, route of administration, and anatomical location were not reported, lot # T018279  had been verified to be a valid number; expiration date 23-NOV-2021) (product administered to patient of inappropriate age). It was reported no further adverse event since administration.
Rt. leg 4 cm X 6 cm warm red area erythema. Right thigh at injection site with 1 cm burst. Reaction to imm/cellulitis area marked.
Approx. 6hrs after receiving injection, I began having swelling and redness distal to injection site. The area became indurated and hot, and I experienced slight dizziness. I took certrizine, applied ice pack. Later took warm shower. In the AM the arm remained reddened and swollen but not indurated and had progressed further distally on left arm. The dizziness persisted when bending over or twisting head. Third day, seems like dizziness has subsided, but the redness and swelling have further progressed to forearm area.
Information has been received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's healthcare provider recommended and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. On or about November 2015, a pharmacist at a pharmacy administered the ZOSTAVAX to the patient. On or about November 2016, the patient was treated by a healthcare provider for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine, and suffered serious physical, emotional and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions (unspecified); lost wages; loss of earnings capacity; and other losses and damages. Additional information has been requested.
Case number PHEH2015US020329 is an initial spontaneous report from a nurse received on 09 Oct 2015. This report refers to a patient of an unknown age and gender. Medical history and concomitant medications were not reported. The patient received expired FLUVIRIN (batch number: not reported) on an unknown date. No adverse event was reported.
About 50 hours after my shot, a headache and very stiff neck and shoulders started. Severe fatigue and very weepy feeling.  Even with ibuprofen and acetaminophen continued to worsen. Next 24 hours severe and made me sleep most of the day. No appetite. The last 21 hours, symptoms lessened and tapering off. But worsen with out meds every 6 hours.
Pt had loose BM x several days prior to vax. 24-48 hr after vax she c/o myalgias and urticarial rash w/ localized edema. On exam she had urticarial lesions arms and fingers w/ mild edema (R) hand/foot.
9:30pm on 12/23/20 i started with a severe headache and then an immediate onset of fatigue, i was unable to stand up and felt like i could not walk. thru at the night i had bodyaches, nightsweats, chills and fever. i had a fever or 101.3 on 12/24/20 for most of the day I rotated tylenol and ibuprofen and was only able to get it too 100.3 . bodyaches and headache continued . 12/25/20 fever and burning of eyes. 12/26/20 -12/27/20 fever and headache.  all symptoms subsided on 12/28/20
Very heavy fatigue, loss of appetite, nausea, left arm ache, poor control of bladder - got up 6 or so times during night to urinate (very little) although I usually get up once a night, sometimes loss of control of bladder during the day.